| Teresa Marie Wertheimer, MD | |
|
2134 Hampton Pl, Okemos, MI 48864-3691 | |
| (517) 347-3000 | |
| (517) 347-8393 |
| Full Name | Teresa Marie Wertheimer |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | 2134 Hampton Pl, Okemos, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811223498 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 4301048709 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Teresa Marie Wertheimer, MD 2134 Hampton Pl, Okemos, MI 48864-3691 Ph: (517) 347-3000 | Teresa Marie Wertheimer, MD 2134 Hampton Pl, Okemos, MI 48864-3691 Ph: (517) 347-3000 |
News Archive
Modified mRNA combined with lipid nanoparticles may be beneficial in boosting adaptive immunity against SARS-CoV-2. Research led by Botond Z. Igyártó from Thomas Jefferson University's Department of Microbiology and Immunology in Pennsylvania recently found that the lipid nanoparticles induce protective adaptive immune responses with antibody titers against lethal doses of the virus.
Medivir AB today announces that the U.S. Food and Drug Administration has granted Priority Review to the New Drug Application by Janssen for simeprevir (TMC435), an investigational NS3/4A protease inhibitor administered as a 150 mg capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease.
Amplimmune, Inc. today announced that it has entered into a broad strategic alliance with GlaxoSmithKline (GSK) to further develop PD-1 targeting therapies that may be effective in the treatment of cancer and other diseases. GSK will obtain exclusive worldwide rights to AMP-224 as well as other potential next generation fusion proteins that target PD-1.
Researchers at Children's Hospital of Philadelphia have found that children with a rare food allergy known as food protein-induced enterocolitis syndrome, or FPIES, have a significantly higher chance of being diagnosed with other allergic conditions, including eczema, traditional food allergy and asthma.
› Verified 2 days ago
Dr. Ralph Joseph Keller Sr., DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 4470 Greenwood Dr, Okemos, MI 48864 Phone: 517-349-2295 Fax: 517-349-3060 | |
Mrs. Andrea G Johnson, CSPOMM DO MB General Practice Medicare: Accepting Medicare Assignments Practice Location: 2501 Jolly Rd, Suite 120, Okemos, MI 48864 Phone: 517-381-0299 Fax: 517-381-9950 |